NCPA Statement on Historic Reduction in U.S. Prescription Drug Spending

Published Online: Thursday, May 9, 2013
Follow Pharmacy_Times:
PRESS RELEASE

ALEXANDRIA, Va. (May 9, 2013) – National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued the following statement today regarding a new study by the IMS Institute for Healthcare Informatics that the total spending on medicines declined by 3.5 percent in 2012 on a real per capita basis to $325.8 billion, falling for the first time in over 50 years:

“This report is generally good news for consumers and health plan sponsors, such as employers. Community pharmacists are proud to have played a key role in achieving the savings reflected in this report. These pharmacists are leading the way in encouraging the appropriate use of more affordable generic prescription drug options.

“A recent analysis of millions of Medicare prescription drug event records found that community pharmacists provided 90-day medication supplies at lower overall cost to Medicare and were more effective at maximizing the proper use of generic drugs compared to mail order pharmacies.

“As the IMS Institute for Healthcare Informatics noted, part of the lower drug spending is unfortunately attributable to economic and other hardships experienced by many consumers. NCPA would like to reiterate that consumers who struggle with paying for their medications should talk to a pharmacist in their community. Pharmacists may be able to identify an appropriate lower-cost drug regimen or other savings. Community pharmacists play a vital role in helping consumers get the most out of their drug benefit.”
Related Articles
The National Community Pharmacists Association issued the following statement today from President John T. Sherrer, RPh in response to the 2014 Gallup survey “U.S. Views on Honesty and Ethical Standards in Professions”:
The National Community Pharmacists Association issued the following statement today from CEO B. Douglas Hoey, RPh, MBA in response to a study by the Centers for Medicare & Medicaid Services of beneficiary access to discounted copays at “preferred” pharmacies in Medicare drug plans.
Today Reps. Doug Collins (R-Ga.) and Dave Loebsack (D-Iowa) introduced H.R. 5815, The Generic Drug Pricing Fairness Act, which creates greater transparency in how pharmacy benefit managers reimburse pharmacies for generic prescription drugs under Medicare Part D, and the Federal Employees Health Benefits Program. The National Community Pharmacists Association endorsed the bill, which goes further than legislation the same two Congressmen introduced earlier year that has the same remedies, but only applied to Medicare Part D.
Joe Moose, PharmD, of Moose Pharmacy, discusses the role of the pharmacist in prevention and reducing readmissions among acute coronary syndrome patients.
Latest Issues
$auto_registration$